|
|
Volumn 70, Issue 1, 2002, Pages 60-63
|
|
Successful long-term control with lamivudine against reactivated hepatitis B infection following intensive chemotherapy and autologous peripheral blood stem cell transplantation in non-hodgkin's lymphoma: Experience of 2 cases
a
|
|
Author keywords
Hepatitis B reactivation; Lamivudine; Lymphoma; Myeloablative chemotherapy
|
|
Indexed keywords
CARBOPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOXORUBICIN;
ETOPOSIDE;
LAMIVUDINE;
MYELOABLATIVE AGENT;
PREDNISOLONE;
RANIMUSTINE;
VINCRISTINE;
ADULT;
ANTIVIRAL ACTIVITY;
ARTICLE;
AUTOTRANSPLANTATION;
CANCER CHEMOTHERAPY;
CASE REPORT;
DRUG EFFICACY;
DRUG INDICATION;
DRUG MEGADOSE;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
HUMAN TISSUE;
LIVER INJURY;
MALE;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
REBOUND;
RISK;
STEM CELL TRANSPLANTATION;
VIREMIA;
VIRUS REACTIVATION;
VIRUS REPLICATION;
VIRUS RESISTANCE;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARRIER STATE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMANS;
LAMIVUDINE;
LYMPHOMA, NON-HODGKIN;
MALE;
MIDDLE AGED;
RECURRENCE;
REVERSE TRANSCRIPTASE INHIBITORS;
TIME FACTORS;
VIRUS ACTIVATION;
|
|
EID: 0036240014
PISSN: 03618609
EISSN: None
Source Type: Journal
DOI: 10.1002/ajh.10084 Document Type: Article |
|
Times cited : (6)
|
|
References (13)
|
